Newest Issue is Out. Get your exclusive copy today.
Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
OxThera AB a privatelyheld biopharmaceutical company dedicated to improving the lives of people with Primary Hyperoxaluria PH announced today that it has completed enrollment in its Oxabact ePHex phase III study
IVERIC bio Inc announced that the US Food and Drug Administration FDA has granted Fast Track designation to Zimura avacincaptad pegol a novel complement C inhibitor in development for the treatment of geographic atrophy GA secondary to dry agerelated...
Care Access Research the leader in rapid development and management of highperforming clinical research sites announced it is leading a validation trial in conjunction with the FDA for a new athome COVID test developed by a private genomics lab that...
Digital Science a leading technology company serving emergent needs across the research sector is pleased to announce a partnership with Beijingbased technology company ZhipuAI to conduct data challenges and collaborate in building a COVID informatio...
SAB Biotherapeutics SAB a clinicalstage biopharmaceutical company advancing a new class of immunotherapies leveraging the native human immune response announced today it has been awarded a contract from the US Department of Defense DoD to develop and...
RedHill Biopharma Ltd a specialty biopharmaceutical company focused on gastrointestinal diseases today announced that it has completed the recently announced acquisition of the global rights excluding Europe Canada and Israel to Movantik naloxegol fo...
Concert Pharmaceuticals Inc announced the details of its pivotal Phase trials of CTP in patients with moderatetosevere alopecia areata an autoimmune disorder that results in patchy or complete hair loss Concert discussed key aspects of its planned P...
GE announced the completion of the sale of its BioPharma business to Danaher Corporation for approximately billion of net proceeds
Eisai Co Ltd and Seikagaku announced today that the companies have entered into an agreement for the codevelopment and marketing alliance in China for SI diclofenac conjugated sodium hyaluronate a therapeutic agent for osteoarthritis discovered by Se...
Phio Pharmaceuticals Corp a biotechnology company developing the next generation of immunooncology therapeutics based on its proprietary selfdelivering RNAi INTASYL therapeutic platform today announced data from various animal studies validating the...
